GEN is a leading pharmaceutical brand that has been serving the Turkish market since 1998. Specializing in the treatment of rare diseases and disorders in various medical branches including Neurology, Endocrinology, Nephrology, Oncology, Hematology, and Pediatrics, GEN is committed to delivering these much-needed products to patients in the most efficient and reliable manner possible. Driven by a vision for a healthy future, GEN combines innovation and partnerships to provide solutions to unmet medical needs.

With over 20 years of steady growth, the brand has become one of the fastest-growing pharmaceutical companies in Turkey. GEN operates a GMP certified production facility in Ankara and has offices in various locations including Ankara, Istanbul, Izmir, Trabzon, Azerbaijan, Kazakhstan, Russia, Germany, Georgia, and Uzbekistan. The brand boasts a team of 500 employees and collaborates with 19 partners from 10 different countries.

GEN's mission is to be flexible and continuously adapt to the changing world, while its quality policy ensures adherence to ethical and scientific principles. They prioritize customer satisfaction, market development, and compliance with national and global regulations. With a focus on ethics, innovation, people-oriented values, reliability, and entrepreneurship, GEN is dedicated to making a positive impact in the pharmaceutical industry and shaping the future of healthcare